Supporting Your Complex Immuno-Oncology Trials

Oncology expertise across adoptive cell therapy, biologics and small molecules

You want to get the right treatments to the right patients. We want to help you develop and execute the most efficient path through the clinic. IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans across multiple treatment modalities (vaccines, bispecific antibodies, adoptive cell therapies [ACT], etc.) and numerous indications across hematologic malignancies and solid tumors. IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans multiple treatment modalities (vaccines, bispecific antibodies, cell and gene therapies (CAGT), etc.) and numerous indications across hematologic malignancies and solid tumors.